Advances in biological sciences and technology have continuously reshaped the questions that researchers are able to address. Over the past several decades, developments in DNA sequencing, mass spectrometry, genome analysis, and omics technologies have transformed not only biomedical research itself, but also the interpretation of observations that previously remained unresolved because of technical limitations. This Editorial reflects on how evolving technologies allow long-standing scientific questions to be revisited across generations of research. Two examples illustrate this process. One concerns the structural re-analysis of a Streptomyces lectin first studied in the 1970s, whose molecular features could only later be clarified through advances in mass spectrometry and expanding genetic databases. The second involves a recent transcriptomic re-examination of ethanol-associated lifespan responses in Caenorhabditis elegans, where modern RNA-seq approaches provided pathway-level insights that were not technically accessible in earlier studies. Together, these examples highlight that scientific progress often emerges not only from asking new questions, but also from revisiting unresolved observations using new technologies and perspectives.
John J. Rossi (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: